Výsledky vyhledávání - "Christoph, Dunau"

Phase I/II clinical study on safety and antivascular effects of paclitaxel encapsulated in cationic liposomes for targeted therapy in advanced head and neck cancer

Autor: Lorenz Jäger, Marc Dellian, Uwe Michaelis, Barbara Wollenberg, Christoph Dunau, Donata Gellrich, Sebastian Strieth

Publikováno v: Head & Neck. 36:976-984

Background The purpose of this phase I/II clinical trial was to test safety and effectiveness of 2 doses of vascular targeting cationic liposomes encapsulating paclitaxel (EndoTAG-1 [ET]) in human head and neck squamous cell carcinoma (HNSCC). Method

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8e4ac46740aea17f805031b9730b1ac0
https://doi.org/10.1002/hed.23397

Zobrazit plný text záznamu

Phase I clinical study of vascular targeting fluorescent cationic liposomes in head and neck cancer

Autor: Barbara Wollenberg, Uwe Michaelis, Martin E. Eichhorn, Sebastian Strieth, Christoph Dunau, Hannelore Ledderose, Donata Strelczyk, Uta Tschiesner, Marc Dellian, Ruth Knuechel, Kristina Kolbow

Publikováno v: European Archives of Oto-Rhino-Laryngology. 270:1481-1487

The aim of this first-time-in-human non-randomized dose-escalating prospective phase I clinical trial was to analyze safety of two doses of fluorescent rhodamine-labeled cationic liposomes (LDF01) in head and neck squamous cell carcinoma (HNSCC). Pat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9889a2e14d06b03e5489cadb87d5a5be
https://doi.org/10.1007/s00405-012-2185-2

Zobrazit plný text záznamu

Klinische Prüfung der Phase I/II von Paclitaxel enkpapsuliert in kationische Liposomen (EndoTAG-1(TM)) zur antivaskulären Targettherapie bei Kopf-Hals-Karzinomen

Autor: Strieth, Sebastian, Christoph, Dunau, Gellrich, Donata, Wollenberg, Barbara, Michaelis, Uwe, Dellian, Marc

Publikováno v: 84. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf-und Hals-Chirurgie; 20130508-20130512; Nürnberg; DOC13hnod290 /20130415/

Einleitung: In tierexperimentellen Studien konnte gezeigt warden, dass sich Paclitaxel enkapsuliert in kationische Liposomen (EndoTAG-1™, ET) zur antivaskulären Targettherapie von malignen Tumoren eignet. Primärer Zielparameter dieser GCP-konform

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08b02d64ca659d704f50e217cfeec636
http://nbn-resolving.de/urn:nbn:de:0183-13hnod2900

Zobrazit plný text záznamu

Phase I/II clinical study on safety and antivascular effects of paclitaxel encapsulated in cationic liposomes for targeted therapy in advanced head and neck cancer

Autor: Sebastian, Strieth, Christoph, Dunau, Uwe, Michaelis, Lorenz, Jäger, Donata, Gellrich, Barbara, Wollenberg, Marc, Dellian

Publikováno v: Headneck. 36(7)

The purpose of this phase I/II clinical trial was to test safety and effectiveness of 2 doses of vascular targeting cationic liposomes encapsulating paclitaxel (EndoTAG-1 [ET]) in human head and neck squamous cell carcinoma (HNSCC).Patients with nonr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::58cb4e91c17cf7d500431e7d331c1cbe
https://pubmed.ncbi.nlm.nih.gov/23733258

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání